Clinical trial / 2006
Consuming fresh grapefruit before meals significantly increased weight loss and reduced 2-hour post-glucose insulin compared to placebo in obese patients.
Ninety-one obese patients were randomized to four groups taking treatments three times daily before meals for 12 weeks: placebo capsules plus apple juice, grapefruit capsules plus apple juice, grapefruit juice plus placebo capsules, or half a fresh grapefruit plus placebo capsules. After 12 weeks, weight loss was 1.6 kg with fresh grapefruit, 1.5 kg with grapefruit juice, 1.1 kg with grapefruit capsules, and 0.3 kg with placebo, with fresh grapefruit showing significantly more weight loss than placebo (P < .05). Among patients with metabolic syndrome, weight loss was significantly greater across all three grapefruit groups compared to placebo (P < .02). Fresh grapefruit also significantly reduced 2-hour post-glucose insulin levels compared with placebo.
- Study type
- Randomized controlled trial
- Who was studied
- 91 obese patients
- What was measured
- Body weight and metabolic syndrome parameters (including 2-hour post-glucose insulin)
THE PAPER
The effects of grapefruit on weight and insulin resistance: relationship to the metabolic syndrome.
Fujioka K, Greenway F, Sheard J, Ying Y. J Med Food, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.